Liang Zhao
Direktor/Vorstandsmitglied bei Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Aktive Positionen von Liang Zhao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
 Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Liang Zhao
Statistik
International
| China | 2 |
Operativ
| Director/Board Member | 1 |
Sektoral
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Börse
- Insiders
- Liang Zhao
- Erfahrung
